An observational cohort study to evaluate the risk of adverse pregnancy outcomes in patients treated with etanercept compared to those not treated with etanercept or other biologics using merged data from Sweden, Denmark and Finland

First published 13/08/2017

Last updated 01/04/2024

EU PAS number:

EUPAS20081

Study

Finalised

Documents

Study protocol

Initial protocol

Enbrel PASS protocol_B1801396_v 3

English (1.05 MB - PDF)View document

Study results

Final report for PASS study B1801396 version 3.0 final

English (1.65 MB - PDF)View document

Study report

Appendix Final report for Etanercept PASS study B1801396_ version 3.0_Final

English (2.22 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs